Molindone: a crossover evaluation of capsule and tablet formulations in severely ill schizophrenic patients

Current Therapeutic Research - Clinical and Experimental

Volumn 15, Issue 12, 1973, Pages 915-918

  Gallant, D M ^a   Bishop, M P ^a   Steele, C A ^a   Bishop, G ^b   Guerrero Figueroa, R ^b  

^a TULANE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; MOLINDONE;

ADVERSE DRUG REACTION; AKATHISIA; BIOAVAILABILITY; BODY WEIGHT; DRUG ABSORPTION; DRUG FORMULATION; DRUG SCREENING; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; INTESTINE ABSORPTION; MAJOR CLINICAL STUDY; MUSCLE RIGIDITY; ORAL DRUG ADMINISTRATION; SCHIZOPHRENIA; THERAPY; TREMOR;

ADMINISTRATION, ORAL; ADULT; ANTIDEPRESSIVE AGENTS; BIOPHARMACEUTICS; CAPSULES; CLINICAL TRIALS; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TABLETS;

EID: 0015719661     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)